JPMorgan Chase & Co’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-46,998
| Closed | -$195K | – | 5994 |
|
|
2022
Q2 | $195K | Buy |
+46,998
| New | +$195K | ﹤0.01% | 4338 |
|
|
2021
Q3 | – | Sell |
-21,707
| Closed | -$153K | – | 5865 |
|
|
2021
Q2 | $153K | Sell |
21,707
-57,345
| -73% | -$404K | ﹤0.01% | 4607 |
|
|
2021
Q1 | $467K | Sell |
79,052
-13,901
| -15% | -$82.1K | ﹤0.01% | 4084 |
|
|
2020
Q4 | $429K | Buy |
92,953
+89,527
| +2,613% | +$413K | ﹤0.01% | 3834 |
|
|
2020
Q3 | $13K | Sell |
3,426
-13,464
| -80% | -$51.1K | ﹤0.01% | 4567 |
|
|
2020
Q2 | $486K | Buy |
16,890
+1,003
| +6% | +$28.9K | ﹤0.01% | 3309 |
|
|
2020
Q1 | $341K | Buy |
15,887
+14,445
| +1,002% | +$310K | ﹤0.01% | 3481 |
|
|
2019
Q4 | $28K | Buy |
+1,442
| New | +$28K | ﹤0.01% | 4377 |
|